Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2018
Source ID
10.1016/j.nicl.2018.03.007

Entities

People

  • Donghuan Lu
  • Ian R. Mackenzie
  • Karteek Popuri
  • Kathryn Alpert
  • Lei Wang
  • Mahadev Bhalla
  • Mirza Faisal Beg
  • Rakesh Balachandar
  • Robin Ging-yuek Hsiung

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Brain Canada Foundation
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Johnson & Johnson Pharmaceutical Research and Development
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • Michael Smith Foundation for Health Research
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • Natural Sciences and Engineering Research Council
  • Pfizer
  • Roche (United States)
  • Takeda (United States)